Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.

A common human cold sore cream may soon help cats with painful eye infections: researchers found that 1% penciclovir cream (Fenlips®), when applied to cats’ eyes, was safe, well-tolerated, and maintained antiviral levels for over eight hours—suggesting that twice-daily use could effectively manage feline herpesvirus type 1, a leading cause of eye disease in cats.

A new cross-national study reveals that older adults with disabilities are significantly less likely to receive preventive care, such as flu vaccinations, eye exams, and dental checkups. This gap remains the same for eye exams and dental care but is eliminated for flu vaccinations in countries that invest more in public healthcare.

The Hebrew University of Jerusalem is proud to announce a new international agreement with the Faculty of Dentistry at the Graduate School of Medical and Dental Sciences, Institute of Science, Tokyo. This agreement marks the beginning of a collaborative partnership focused on research, and the mutual exchange of students and academic staff.

The Tokyo institute is globally recognized for excellence. Its Faculty of Dentistry holds an impressive 4th place in QS 2025 Subject Rankings!